Combination of nivolumab and ipilimumab improved overall survival of patients with unresectable malignant pleural mesothelioma compared to platinum-based chemotherapy, according to a study.
The research is presented at the International Association for the Study of Lung Cancer Virtual Presidential Symposium.The study is presented by Paul Baas, M.D., from The Netherlands Cancer Institute and The University of Leiden, in Amsterdam.
bNivolumab/b is an immunotherapy that works as a checkpoint ...
Combination of nivolumab and ipilimumab improved overall survival of patients with unresectable malignant pleural mesothelioma compared to platinum-based chemotherapy, according to a study.
The research is presented at the International Association for the Study of Lung Cancer Virtual Presidential Symposium.The study is presented by Paul Baas, M.D., from The Netherlands Cancer Institute and The University of Leiden, in Amsterdam.
bNivolumab/b is an immunotherapy that works as a checkpoint ...